EGFR and non-small cell lung carcinoma: Both EGFR mutations and amplifications are a driving force behind many cancers including breast, non-small cell lung carcinoma (NSCLC), glioblastoma, head and neck squamous cell carcinoma (HNSCC), ovarian and melanoma [8].